Monogenic diabetes: implications for therapy of rare types of disease.
about
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1α.Induced pluripotent stem cells as a model for diabetes investigation.Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
P2860
Monogenic diabetes: implications for therapy of rare types of disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Monogenic diabetes: implications for therapy of rare types of disease.
@ast
Monogenic diabetes: implications for therapy of rare types of disease.
@en
type
label
Monogenic diabetes: implications for therapy of rare types of disease.
@ast
Monogenic diabetes: implications for therapy of rare types of disease.
@en
prefLabel
Monogenic diabetes: implications for therapy of rare types of disease.
@ast
Monogenic diabetes: implications for therapy of rare types of disease.
@en
P1476
Monogenic diabetes: implications for therapy of rare types of disease.
@en
P2093
Maciej T Malecki
Wojciech Mlynarski
P2860
P304
P356
10.1111/J.1463-1326.2007.00736.X
P577
2007-05-06T00:00:00Z